White House Issues Order under Defense Production Act as Part of COVID Response
Client Alert | 1 min read | 03.19.20
On March 18, 2020, President Trump significantly expanded the authority delegated to the Secretary of Health and Human Services (HHS) in his “Executive Order on Prioritizing and Allocating Health and Medical Resources to Respond to the Spread of Covid-19.” The Order is based on a finding that, “to ensure that our healthcare system is able to surge capacity and capability to respond to the spread of COVID-19, it is critical that all health and medical resources needed to respond to the spread of COVID-19 are properly distributed to the Nation’s healthcare system and others that need them most at this time.”
Specifically, the Order delegated to the Secretary the authority to require performance of contracts or orders (other than contracts of employment) over performance of any other contracts or orders, and to allocate materials, services, and facilities as deemed necessary or appropriate. The Order also authorized the HHS Secretary to determine the proper nationwide priorities and allocation of all health and medical resources, including controlling the distribution of such materials (including applicable services) in the civilian market, for responding to the spread of COVID-19 within the United States, and may issue such orders and adopt and revise appropriate rules and regulations as may be necessary. This grant of authority to HHS is quite broad and apparently distinct from existing requirements and limitations of the Defense Priority and Allocation System regulations set forth in 15 CFR Part 700. The Order leaves open a number of questions that will need to be addressed by the Secretary, including the impact on existing medical supply contracts and healthcare providers’ and suppliers’ abilities to manage the allocation of healthcare resources to treat their patients.
Contacts
Insights
Client Alert | 4 min read | 09.23.25
A Special Relationship Reboot? The US-UK Tech Prosperity Deal
On 18 September, during the anticipated state visit, the leaders of the UK and the US signed the Technology Prosperity Deal, which promises to boost investment and cooperation to foster innovation, security, and economic prosperity. This is being lauded in the UK as a hugely significant milestone in transatlantic cooperation. The governments of both countries have released a Memorandum of Understanding (“Memo”) which covers a number of ambitious plans in strategic science and technology fields, including artificial intelligence (“AI”), nuclear energy, fusion, and quantum technologies.
Client Alert | 7 min read | 09.23.25
Client Alert | 2 min read | 09.23.25
The Other PFAS Shoe Drops: EPA Will Retain and Defend Its CERCLA PFAS Regulation
Client Alert | 2 min read | 09.22.25
Department of Education Discontinues Discretionary Grant Funding for Minority-Serving Institutions